Submitted by Anonymous (not verified) on 29 October 2026 - 15:02
Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 12, Status: Authorised
Source: